After completing the necessary formulation work with its experienced internal product development team, Omniblend has secured opening orders from these clients for a combined value of more than A$1,300,000 (US$891,000).
The commercial arrangements do not stipulate specific volume of production, rather they set out the terms on which the company will contract manufacture private label product, as and when orders are placed.
The destination of the products is to domestic and international markets, including China, South East Asia and the Middle East.
Keytone’s chief executive officer, Danny Rotman, said, “We are extremely pleased to continue to secure the caliber of clients such as these. Omniblend is a leading health and wellness manufacturer and it is testament to our operations that major international health and wellness brands continue to choose to work with us. We look forward to developing a long-term relationship and offering these clients the expertise and manufacturing capabilities the business brings.”